Tag: HEB

Blue Horseshoe Stocks: APT, VTAE, NEWC & More

Alpha Pro Tech Ltd. APT 

Here’s a past gainer that began to catch our attention yesterday- We jumped on APT for the first time back on October 10th, while the stock was in the middle of a huge run. We observed the low of 5.72 on that day, and the stock took just two more sessions to reach a high of 10.73, marking a move of 87%

Following that big spike, APT had been beaten back over the past couple weeks, and this week, has begun to bounce off support above the 50DMA (3.58). We want to pay attention as the stock attempts a recovery.

Vitae Pharma, Inc. VTAE

We want to put VTAE on our radar as we close out the week, and keep an eye on it moving forward. The stock is gapping up big this morning; it had already been on the incline prior to yesterday’s news that really served to heat things up.

VTAE announced it had received positive results from a couple of its Phase-1 trials for an Alzheimer’s treatment they claim “Demonstrated Greater Than 80% Reduction of an Alzheimer’s Disease Biomarker” >> VIEW PR

The statement indicated that the results would lead to further trials over the next several months, so we’re going to enter VTAE into the log and reserve it a spot on our watchlists.

New Columbia Resources, Inc. NEWC

NEWC is a play we want to radar and add to our expansive marijuana-stock watchlist. We’re always keeping our eyes peeled for new cannabis stocks to watch, and we caught this one on a news scan today.

The company announced that its “Colombian subsidiary, Sannabis S.A.S., has legally produced  a trial run of cannabis based products on an Indian reservation.”

Infinera Corp. INFN

INFN appeared in yesterday’s report and made a decent move on strong volume, to the tune of nearly 10X the monthly average. The stock traded in a range from 12.17-13.96, a 15% intraday increase. We’ll be keeping watch over this play into next week as well.

Extended Watchlist:
OMEX, HEB, RUBI, IBIO

Blue Horseshoe Stocks: Friday Recap, DRL & More

Reviewing Friday’s Top Picks

iBio, Inc. IBIO

The number one mover from our Friday morning report was undoubtedly IBIO. Our recent observation that increasing concerns over the presence of the Ebola virus on American soil would drive related stocks paid off in spades.

IBIO was among those to get a huge boost on unconfirmed reports that it would aid in government efforts to speed production of the ZMapp experimental Ebola treatment.

The stock would see a low of .89 near the beginning of the session, and ended up running extremely hard into the close, reaching a high of 1.57. That equals out to an intraday surge of 76% but our total possible gains didn’t stop there. The stock continues to roll this morning, having hit a high of 2.76 in the premarket and pushing the total amount of the increase we’ve seen on IBIO since Friday morning to an impressive 210%


Alpha Pro Tech Ltd. APT

Like IBIO, APT was also affected by Ebola fears on Friday, and traded in a less extreme but similar pattern. After seeing a morning low of 5.72, the stock pushed the envelope into the close, reaching a peak of 7.43 for a 30% intraday gain. It is also gapping up bigtime today, with a premarket high of 9.25, which marks a 62% move up from Friday morning’s low.

Doral Financial Corp. DRL

Some of our more seasoned subscribers will certainly remember our coverage of DRL this year. We were waiting to get word on the company’s tax suit against the Puerto Rican governement, and Friday following market close, it was announced that the court has ruled in favor of Doral, which will be due the disputed-over sum of $229M.

As a result of this untraded-upon news, the stock is gapping up like crazy today, to the tune of a 9.46 premarket high, up well over 100% above the low we observed following our initial alert on DRL this summer.

We’ll probably see some selling pressure from profit taking in a situation like this, so we’ll be on the lookout for a potential dip-and-rip scenario to kick off the week.

Extended Watchlist:
AHPI, HEB, NSPH, SMED, FOMX, OBCI,

Blue Horseshoe Stocks: Bottom Play Alert, HEB & More

FBC Holdings, Inc. FBCD

We wanted send out an alert on FBCD this morning, if for no other reason than the fact that it’s been quite awhile since we found a bottom play trading near all-time lows in the super-subpenny range. We’ve definitely been known to do some bottom-fishing in our day, with some of our biggest wins coming from bargain shopping.

What we have in FBCD is a stock that has been beaten back to a record low of .0005 (reached yesterday) which catches our attention in a big way. We are going to stay vigilant as we monitor this play for a solid bottom, because a snapback to to the double-zero range is not only very possible, but also has the potential to happen quite rapidly.

With so little room to the downside, one might classify FBCD as a “lottery ticket” type of play. The action on super-subpennies have the potential to return exponential gains, which is why we’re going to give it a spot on our running watchlist.

A quick glance at the chart shows that each time an influx of volume has come into the stock, it makes a run to test its 50DMA. From present levels, a jump to the current 50DMA would mean a chance for gains of at least 66%

Hemishperx BioPharma, Inc. HEB

We were passively tracking HEB via our extended watchlist last month, and are going to keep giving it our attention as the new quarter kicks off today. The stock is gapping up to the tune of roughly 25% in the premarket.

We caught notice of HEB following the company’s announcement that it would collaborate with US Army Medical Research to develop treatments to attempt to overcome the emergence of drug resistance due to Ebola virus mutation.

With the current Ebola breakout making it a hot-button topic, and the company stating this week that it would be expanding its Ebola research, we’re going to still be keeping our ears to the ground on this one.

Spherix, Inc. SPEX

SPEX made an appearance in yesterday morning’s extended watchlist and had one heck of a solid session. The stock came out of the gate and ran from a low of .99 all the way up to 1.58, offering us the chance to bank up to 60% in profits as it traded more than 13.5X its 3-month average volume.

Disappointment over the delay of some upcoming litigation that Shperix has against VTech and Uniden (View PR) is the apparent cause of the stock’s gapping down in today’s premarket.

Extended Watchlist:
LAKE, BCRX, ANGI, RVP, NNVC, CGA